xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).
mertolok 100 mg depottabletter
farmaprojects, s.a. - metoprololsuccinat - depottabletter - 100 mg
mertolok 200 mg depottabletter
farmaprojects, s.a. - metoprololsuccinat - depottabletter - 200 mg
mertolok 25 mg depottabletter
farmaprojects, s.a. - metoprololsuccinat - depottabletter - 25 mg
mertolok 50 mg depottabletter
farmaprojects, s.a. - metoprololsuccinat - depottabletter - 50 mg
metoprololsuccinat "farmaprojects" 100 mg depottabletter
farmaprojects, s.a. - metoprololsuccinat - depottabletter - 100 mg
metoprololsuccinat "farmaprojects" 25 mg depottabletter
farmaprojects, s.a. - metoprololsuccinat - depottabletter - 25 mg
metoprololsuccinat "farmaprojects" 50 mg depottabletter
farmaprojects, s.a. - metoprololsuccinat - depottabletter - 50 mg
tenidon mite 50 + 12,5 mg filmovertrukne tabletter
viatris limited - atenolol, chlortalidon - filmovertrukne tabletter - 50 + 12,5 mg
vildagliptin/metformin "teva" 50+1000 mg filmovertrukne tabletter
teva b.v. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg